Wolfgang Weger
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study.
Journal: Psoriasis (Auckland, N.Z.)
Published: January 05, 2026
Associations between mental health and disease severity in individuals with psoriasis.
Journal: Skin health and disease
Published: November 15, 2025
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study.
Journal: American journal of clinical dermatology
Published: March 24, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study.
Journal: Psoriasis (Auckland, N.Z.)
Published: March 06, 2025
Predictors of treatment survival in patients with plaque psoriasis treated with phototherapy: registry analysis.
Journal: Skin health and disease
Published: February 28, 2025
Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival - a retrospective registry study.
Journal: The British journal of dermatology
Published: February 08, 2025
Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment.
Journal: Journal of dermatological science
Published: January 30, 2025
Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA).
Journal: Scientific reports
Published: March 27, 2024
Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis.
Journal: Research square
Published: February 27, 2024
Happiness across the borders-A cross-sectional study among patients with psoriasis and atopic dermatitis in Europe.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 14, 2024
Psoriasis and its impact on close relatives and partners of patients - A cross-sectional questionnaire study.
Journal: Skin health and disease
Published: November 24, 2023
No impact of disease duration on response to tildrakizumab treatment among patients with moderate-to-severe plaque psoriasis: Post hoc analyses from two phase 3 (reSURFACE 1 and reSURFACE 2) and one phase 4 (TRIBUTE) studies.
Journal: Skin health and disease
Published: October 06, 2023
Last Updated: 09/26/2026